Utilizing CMP-Sialic Acid Analogs to Unravel Neisseria gonorrhoeae Lipooligosaccharide-Mediated Complement Resistance and Design Novel Therapeutics

• Sunita Gulati,

  Affiliation Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  ⨯
• Ian C. Schoenhofen ,

  * E-mail: ian.schoenhofen@nrc-cnrc.gc.ca (ICS); sanjay.ram@umassmed.edu (SR)

  Affiliation Human Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, Canada

  ⨯
• Dennis M. Whitfield,

  Affiliation Human Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, Canada

  ⨯
• Andrew D. Cox,

  Affiliation Human Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, Canada

  ⨯
• Jianjun Li,
• Frank St. Michael,

  Affiliation Human Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, Canada

  ⨯
• Evgeny V. Vinogradov,

  Affiliation Human Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, Canada

  ⨯
• Jacek Stupak,

  Affiliation Human Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, Canada

  ⨯
• Bo Zheng,

  Affiliation Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  ⨯
• Makoto Ohnishi,

  Affiliation National Institute of Infectious Diseases, Tokyo, Japan

  ⨯
• Magnus Unemo,

  Affiliation WHO Collaborating Centre for Gonorrhoea and Other STIs, Department of Laboratory Medicine, Microbiology, Örebro University Hospital, Örebro, Sweden

  ⨯
• Lisa A. Lewis,

  Affiliation Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  ⨯
• Rachel E. Taylor,

  Affiliation Biomedical Sciences Graduate Program, Departments of Medicine and Cellular and Molecular Medicine, Glycobiology Research and Training Center, University of California, San Diego, La Jolla, California, United States of America

  ⨯
• Corinna S. Landig,

  Affiliation Biomedical Sciences Graduate Program, Departments of Medicine and Cellular and Molecular Medicine, Glycobiology Research and Training Center, University of California, San Diego, La Jolla, California, United States of America

  ⨯
• Sandra Diaz,

  Affiliation Biomedical Sciences Graduate Program, Departments of Medicine and Cellular and Molecular Medicine, Glycobiology Research and Training Center, University of California, San Diego, La Jolla, California, United States of America

  ⨯
• George W. Reed,

  Affiliation Preventive and Behavioral Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  ⨯
• Ajit Varki,

  Affiliation Biomedical Sciences Graduate Program, Departments of Medicine and Cellular and Molecular Medicine, Glycobiology Research and Training Center, University of California, San Diego, La Jolla, California, United States of America

  ⨯
• Peter A. Rice,

  Affiliation Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  ⨯
•  [ ... ],
• Sanjay Ram

  * E-mail: ian.schoenhofen@nrc-cnrc.gc.ca (ICS); sanjay.ram@umassmed.edu (SR)

  Affiliation Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  ⨯
• [ view all ]
• [ view less ]